Veru, Inc. (VERU)
2.77
+0.44 (18.88%)
Upcoming Events
Latest Headlines
Form 10-Q VERU INC. For: Jun 30
August 10, 2026 8:52 AM - SEC Filing
Veru, Inc. (VERU) Tops Q3 EPS by 1c
August 10, 2026 8:13 AM - StreetInsider
Form 8-K VERU INC. For: Aug 10
August 10, 2026 7:00 AM - SEC Filing
Veru posts Q3 loss, reports full enrollment in obesity drug trial
August 10, 2026 6:30 AM - StreetInsider
Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
August 10, 2026 6:30 AM - Globe NewsWire
Veru receives patent allowance for enobosarm and semaglutide combo
August 4, 2026 8:30 AM - StreetInsider
Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss
August 4, 2026 8:30 AM - Globe NewsWire
Veru to Report Fiscal 2026 Third Quarter Financial Results on August 10th
August 3, 2026 8:30 AM - Globe NewsWire
Veru to Participate in Fireside Chat at the Canaccord Genuity's 46th Annual Growth Investors Conference
July 30, 2026 8:30 AM - Globe NewsWire
Veru completes enrollment in Phase 2b obesity combination drug trial
July 27, 2026 8:10 AM - StreetInsider
Veru Announces Full Enrollment for Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
July 27, 2026 8:10 AM - Globe NewsWire
Veru to Present at 2026 Obesity & Weight Loss Drug Development Summit and Pre-Conference Workshop Day
July 7, 2026 8:30 AM - Globe NewsWire
Veru sets up $21.8M at-the-market stock offering
July 2, 2026 4:12 PM - StreetInsider
Form 8-K VERU INC. For: Jul 02
July 2, 2026 4:09 PM - SEC Filing
Form 424B5 VERU INC.
July 2, 2026 4:07 PM - SEC Filing
Oppenheimer Reiterates Outperform Rating on Veru, Inc. (VERU)
June 4, 2026 1:03 PM - StreetInsider
Veru partners with Novo Nordisk for obesity drug combination study
June 4, 2026 8:42 AM - StreetInsider
Form 8-K VERU INC. For: Jun 02
June 4, 2026 8:30 AM - SEC Filing
Veru, Inc. (VERU) PT Lowered to $24 at Oppenheimer
May 15, 2026 7:48 AM - StreetInsider
Form S-8 VERU INC.
May 13, 2026 9:20 AM - SEC Filing
Form 10-Q VERU INC. For: Mar 31
May 13, 2026 9:10 AM - SEC Filing
Form 8-K VERU INC. For: May 13
May 13, 2026 7:00 AM - SEC Filing
Veru, Inc. (VERU) Misses Q2 EPS by 13c
May 13, 2026 6:41 AM - StreetInsider
Veru reports second quarter fiscal 2026 results and obesity trial update
May 13, 2026 6:30 AM - StreetInsider
Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
May 13, 2026 6:30 AM - Globe NewsWire
Full Article List
